Forte Biosciences Prices $75 Mln Public Offering Of Common Stock And Pre-Funded Warrants
26/6 00:00
(RTTNews) - Forte Biosciences, Inc. (FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and related diseases, has priced a public offering of 5,630,450 shares of common stock at $12.00 per share....